System Assessment Report Relating to Electronic Records and Electronic Signatures; 21 CFR Part 11

Importance of the topic

The implementation of 21 CFR Part 11 ensures the integrity, authenticity, and reliability of electronic records and signatures in regulated environments. Compliance is critical for pharmaceutical, biotech, and QA/QC laboratories where automated data acquisition and analysis must meet FDA requirements.

Goals and overview

This assessment evaluates the Metrohm 916 Ti-Touch (Firmware 5.916.0045) against the 21 CFR Part 11 checklist. Key objectives include verifying system validation, audit trail completeness, report generation, data retention, user access controls, and electronic signature functionality.

Methodology and instrumentation

The evaluation follows a structured checklist covering closed‐system provisions (11.10–11.70) and open‐system considerations (11.30). Testing involved:

• 916 Ti-Touch analyser with Touch Control interface
• Connected balances (RS-232), barcode scanners, and keyboards via USB
• Audit Trail Viewer software and USB storage media for export
• IQ/OQ documentation and Metrohm validation services

Main results and discussion

• Validation (11.10(a)): The instrument is capable of full IQ/OQ validation; Metrohm supplies documentation and support.
• Audit trail (11.10(a),(e)): Secure, ISO 8601–timestamped logs record all operator actions, modifications, and reasons; exportable internally or via USB and viewable in PDF or text format.
• Report generation (11.10(b)): Configurable paper and electronic reports include timestamps and user IDs; automatic print or PDF output ensures data integrity.
• Record retention (11.10(c)): Methods and determinations are archived using binary backups with checksum protection; retrieval is straightforward on any Touch Control device.
• Access control (11.10(d),(g)): Role-based logins and user profiles enforce authorization; two‐level electronic signatures prevent self-signing for review and release.
• Device management (11.10(f),(h),(k)): Automatic detection and plausibility checks of connected instruments maintain measurement sequence and device validity; configuration changes are traceable.
• Open system provisions (11.30): Network access is not available; data files include checksums to detect unauthorized modification during transfer.
• Electronic signatures (11.50–11.200): Unique user ID and password combinations support signing events; signature metadata (name, date/time, reason) are embedded in records and printouts, and signatures are irrevocably linked to corresponding data.
• Password and ID controls (11.300): Enforced password complexity, periodic expiration, account disabling for compromised credentials, and checksum-protected user profiles ensure secure authentication.

Benefits and practical applications

• Full FDA compliance for electronic data handling in regulated labs.
• Comprehensive audit readiness through detailed traceability and reporting.
• Enhanced data integrity and security in automated titrations.
• Streamlined validation and quality assurance processes.

Future trends and opportunities

• Integration with cloud-based LIMS and secure remote monitoring under evolving Part 11 guidance.
• Advanced audit‐trail analytics for process optimization and predictive maintenance.
• Adoption of biometric or token‐based multi-factor authentication.
• AI-driven validation and compliance documentation tools.

Conclusion

The Metrohm 916 Ti-Touch system demonstrates robust compliance with 21 CFR Part 11 closed‐system requirements. Its built-in validation support, comprehensive audit trails, secure reporting, record retention, and electronic signature capabilities, combined with operator-defined SOPs for training and change control, provide a solid platform for regulated laboratories.

Used Instrumentation

• 916 Ti-Touch analyser (Firmware 5.916.0045)
• Metrohm Touch Control interface
• RS-232 connected balances
• USB barcode scanners and keyboards
• Audit Trail Viewer software
• USB storage media for backups and exports